These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30860160)

  • 21. Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
    Kuwabara S; Nakata M; Sung JY; Mori M; Kato N; Hattori T; Koga M; Yuki N
    J Neurol Sci; 2002 Jul; 199(1-2):89-92. PubMed ID: 12084449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection.
    Rajabally YA; Kass-Hout T; Wilson P; Damian MS
    Eur J Neurol; 2007 Mar; 14(3):e11-2. PubMed ID: 17355531
    [No Abstract]   [Full Text] [Related]  

  • 25. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Neisser A; Schwerer B; Bernheimer H; Moran AP
    J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell recognition of a non-protein antigen preparation of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Cooper JC; Hughes S; Ben-Smith A; Savage CO; Winer JB
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):413-4. PubMed ID: 11861714
    [No Abstract]   [Full Text] [Related]  

  • 27. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
    Koga M; Takahashi M; Yokoyama K; Kanda T
    J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
    Ebrahim Soltani Z; Rahmani F; Rezaei N
    Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guillain-Barré syndrome].
    Koga M; Yuki N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):35-8. PubMed ID: 11269101
    [No Abstract]   [Full Text] [Related]  

  • 31. Guillain-Barré Syndrome After Zika Virus Infection in Brazil.
    do Rosário MS; de Jesus PA; Vasilakis N; Farias DS; Novaes MA; Rodrigues SG; Martins LC; Vasconcelos PF; Ko AI; Alcântara LC; de Siqueira IC
    Am J Trop Med Hyg; 2016 Nov; 95(5):1157-1160. PubMed ID: 27645785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

  • 33. New concepts of Guillain-Barré syndrome.
    Asbury AK
    J Child Neurol; 2000 Mar; 15(3):183-91. PubMed ID: 10757475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Guillain-Barré syndrome].
    Kusunoki S
    Nihon Rinsho; 2005 May; 63 Suppl 5():427-31. PubMed ID: 15954387
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.
    Jasti AK; Selmi C; Sarmiento-Monroy JC; Vega DA; Anaya JM; Gershwin ME
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1175-1189. PubMed ID: 27292311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from Greece.
    Chatzipanagiotou S; Kilidireas K; Trimis G; Nicolaou C; Anagnostouli M; Athanassaki C; Giannoulia A; Legakis N; Youroukos S
    Clin Microbiol Infect; 2003 Jan; 9(1):69-72. PubMed ID: 12691547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
    Odaka M; Koga M; Yuki N; Susuki K; Hirata K
    J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine treatment reduces the incidence of flaccid paralysis in a zika virus mouse model of temporary paralysis with similarities to Guillain-Barré syndrome.
    Siddharthan V; Wang H; de Oliveira AL; Dai X; Morrey JD
    Antivir Chem Chemother; 2020; 28():2040206620950143. PubMed ID: 34161179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.